The Claim

Higher plasma copeptin levels are associated with a 49% increased risk of developing type 2 diabetes in women over a median follow-up of 7.7 years, independent of fasting glucose, hs-CRP, and urinary albumin excretion.

Source: Sex differences in the association between plasma copeptin and incident type 2 diabetes: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study

What the research says

Supports is higher

Support is ahead, but a single strong opposing study can change this.

Supports
59score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

Correlation
1 study reviewed
In plain English

Women with higher levels of copeptin in their blood have a 49% higher chance of developing type 2 diabetes over about 7.7 years, even when accounting for other known risk factors like blood sugar and inflammation markers.

See the scientific wording

Higher plasma copeptin levels are associated with a 49% increased risk of developing type 2 diabetes in women over a median follow-up of 7.7 years, independent of established risk factors including fasting glucose, hs-CRP, and urinary albumin excretion, suggesting copeptin may serve as a sex-specific biomarker for diabetes risk prediction.

Why this might work

When stress or other signals cause the brain to release more vasopressin, the body produces more copeptin as a byproduct. This vasopressin acts on the liver to force it to release more sugar into the blood and on the pancreas to change how much insulin is released. In women, these effects are stronger because their liver and pancreas cells respond more intensely to vasopressin, leading to higher blood sugar over time and eventually type 2 diabetes.

Supported mechanismbased on 1 study

What the research says

1 study

  1. Study: Sex differences in the association between plasma copeptin and incident type 2 diabetes: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study

    This study found that women with higher levels of a blood protein called copeptin are almost 50% more likely to develop type 2 diabetes later, even when doctors already know their blood sugar and kidney health. This means copeptin could help spot women at higher risk.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.